Literature DB >> 18669553

Clearance of acanthosis nigricans associated with insulinoma following surgical resection.

S Ghosh1, B Roychowdhury, S Mukhopadhyay, S Chowdhury.   

Abstract

Acanthosis nigricans is said to be a marker of insulin resistance. It is known to occur in patients with insulinoma where there is marked hyperinsulinaemia. We report a case wherein the acanthosis disappeared following surgical resection of insulinoma and this strengthens the hypothesis that hyperinsulinaemia is responsible for acanthosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669553     DOI: 10.1093/qjmed/hcn098

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  6 in total

1.  Acanthosis nigricans in insulinoma: before and after successful surgical enucleation.

Authors:  Shinjan Patra; Partha Pratim Chakraborty; Himanshu Barman; Gouranga Santra
Journal:  BMJ Case Rep       Date:  2016-11-11

2.  Acanthosis nigricans in Insulinoma: Reversible experiments of the nature.

Authors:  Vijay Sheker R Danda; Paidipally Srinivas Rao; Chaitanya Konda; Piyush Lodha
Journal:  Med J Armed Forces India       Date:  2019-10-18

3.  Acanthosis nigricans in a patient with metastatic insulinoma post peptide receptor radionuclide therapy.

Authors:  Jenny S W Yun; Chris McCormack; Michelle Goh; Cherie Chiang
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-06-01

4.  Acanthosis nigricans in insulinoma.

Authors:  Viveka P Jyotsna; Nishant Raizada; Semanti Chakraborty; S Pal
Journal:  Indian J Endocrinol Metab       Date:  2014-09

Review 5.  Current treatment options for acanthosis nigricans.

Authors:  Nupur U Patel; Catherine Roach; Hossein Alinia; William W Huang; Steven R Feldman
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-08-07

6.  Insulinoma masquerading as a loss of consciousness in a teenage girl: case report and literature review.

Authors:  Meghana Gudala; Mahmuda Ahmed; Rushika Conroy; Ksenia Tonyushkina
Journal:  Int J Pediatr Endocrinol       Date:  2017-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.